These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 10947894)

  • 1. Markers of hypercoagulation and von Willebrand factor in postmenopausal women with unstable coronary artery disease. Discriminatory ability regarding unstable coronary artery disease and coronary atherosclerosis using receiver operating characteristics.
    Nielsen NE; Siegbahn A; Swahn E
    J Intern Med; 2000 Aug; 248(2):151-8. PubMed ID: 10947894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma lipoprotein particle concentrations in postmenopausal women with unstable coronary artery disease. Analysis of diagnostic accuracy using receiver operating characteristics.
    Nielsen NE; Olsson AG; Swahn E
    J Intern Med; 2000 Jan; 247(1):43-52. PubMed ID: 10672130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrinolytic variables in postmenopausal women with unstable coronary artery disease.
    Nielsen NE; Logander E; Swahn E
    J Thromb Thrombolysis; 2001 Dec; 12(3):217-23. PubMed ID: 11981104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma total homocysteine levels in postmenopausal women with unstable coronary artery disease.
    Nielsen NE; Brattström L; Hultberg B; Landgren F; Swahn E
    Atherosclerosis; 2000 Aug; 151(2):423-31. PubMed ID: 10924719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Decreased plasma soluble P-selectin level in coronary sinus after successful coronary angioplasty in patients with unstable angina].
    Doi N; Nishio K; Nakatani H; Hayashi T; Miyamoto S; Hashimoto T; Dohi K
    J Cardiol; 1999 May; 33(5):251-6. PubMed ID: 10354952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma vaspin concentrations are decreased in acute coronary syndrome, but unchanged in patients without coronary lesions.
    Zhang B; Peng W; Li H; Lu Y; Zhuang J; Wang K; Su Y; Xu Y
    Clin Biochem; 2013 Oct; 46(15):1520-5. PubMed ID: 23850850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma levels of cyclic GMP and endothelin in postmenopausal women with unstable coronary artery disease.
    Nielsen NE; Ahlner J; Malmstedt J; Ohman KP; Swahn E
    Scand J Clin Lab Invest; 1999 Aug; 59(5):325-34. PubMed ID: 10533844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Changes of plasma von Willebrond factor and soluble E-selectin levels in patients with coronary artery disease].
    Lin GQ; Jiang HH; Li YQ
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Aug; 30(4):399-402. PubMed ID: 16190382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating Serum Levels of Pentraxin-3, von Willebrand Factor and C-X-C Motif Chemokine Ligand 13 as Inflammatory Markers of Unstable Angina Pectoris.
    Raygan F; Mohammadi H; Etminan A; Sehat M; Nikoueinejad H
    Iran J Allergy Asthma Immunol; 2019 Apr; 18(2):200-208. PubMed ID: 31066256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between brain-derived neurotrophic factor and von Willebrand factor levels in patients with stable coronary artery disease.
    Jin H; Chen Y; Wang B; Zhu Y; Chen L; Han X; Ma G; Liu N
    BMC Cardiovasc Disord; 2018 Feb; 18(1):23. PubMed ID: 29409455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of association between haemostatic variables and the presence or the extent of coronary atherosclerosis.
    Schmitz-Huebner U; Thompson SG; Balleisen L; Fechtrup C; Grosse-Heitmeyer W; Kirchhof B; Most E; Müller US; Seiffert C; Seiffert D
    Br Heart J; 1988 Mar; 59(3):287-91. PubMed ID: 3258521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antithrombin III supplementation for patients undergoing PTCA for unstable angina pectoris. A controlled randomized double-blind pilot study.
    Grip L; Blombäck M; Egberg N; Olsson A; Svane B; Velander M
    Eur Heart J; 1997 Mar; 18(3):443-9. PubMed ID: 9076381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prothrombin fragments F1+2, thrombin-antithrombin III complexes, fibrin monomers and fibrinogen in patients with coronary atherosclerosis.
    Giannitsis E; Siemens HJ; Mitusch R; Tettenborn I; Wiegand U; Schmücker G; Sheikhzadeh A; Stierle U
    Int J Cardiol; 1999 Mar; 68(3):269-74. PubMed ID: 10213277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early increase of von Willebrand factor predicts adverse outcome in unstable coronary artery disease: beneficial effects of enoxaparin. French Investigators of the ESSENCE Trial.
    Montalescot G; Philippe F; Ankri A; Vicaut E; Bearez E; Poulard JE; Carrie D; Flammang D; Dutoit A; Carayon A; Jardel C; Chevrot M; Bastard JP; Bigonzi F; Thomas D
    Circulation; 1998 Jul; 98(4):294-9. PubMed ID: 9711933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low paraoxonase 1 arylesterase activity and high von Willebrand factor levels are associated with severe coronary atherosclerosis in patients with non-diabetic stable coronary artery disease.
    Ding J; Chen Q; Zhuang X; Feng Z; Xu L; Chen F
    Med Sci Monit; 2014 Nov; 20():2421-9. PubMed ID: 25420483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk stratification and prognostic implication of plasma biomarkers in nondiabetic patients with stable coronary artery disease: the role of high-sensitivity C-reactive protein.
    Leu HB; Lin CP; Lin WT; Wu TC; Chen JW
    Chest; 2004 Oct; 126(4):1032-9. PubMed ID: 15486359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atherogenic index of plasma (AIP): a novel predictive indicator for the coronary artery disease in postmenopausal women.
    Wu TT; Gao Y; Zheng YY; Ma YT; Xie X
    Lipids Health Dis; 2018 Aug; 17(1):197. PubMed ID: 30134981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Relation of an increase of von Willebrand factor in the blood, acute myocardial infarction, unstable angina and coronary thrombosis].
    Mossard JM; Wiesel ML; Cazenave JP; Grunebaum L; Drawin T; Kieny JR; Roul G; Bareiss P; Sacrez A
    Arch Mal Coeur Vaiss; 1989 Nov; 82(11):1813-8. PubMed ID: 2514633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue factor pathway inhibitor, natural coagulation inhibitors and hemostatic activation markers in patients with acute coronary syndromes.
    Al-Nozha MM; Abdel-Gader AG; Arafah MR; Al-Maatouq MA; Al-Shahid MS; Al-Harthi SS; Khan NB; Abdullah MA
    Saudi Med J; 2005 Jun; 26(6):937-42. PubMed ID: 15983678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative short-term prognostic value of hemostatic and inflammatory markers in patients with non-ST elevation acute coronary syndromes.
    Passoni F; Morelli B; Seveso G; Lazzati L; Beria G; Del Rosso G; D'Urbano M; Cafiero F; Mariani G; De Servi S
    Ital Heart J; 2002 Jan; 3(1):28-33. PubMed ID: 11899586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.